Clinical Trial Update: The Effect of Inflammation and Damage to Lymph Node Structures on Durable Protective Immunity Following Yellow Fever Vaccination [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial update evaluating how inflammation and lymph node damage after yellow fever vaccination affect the durability of protective immunity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Yellow Fever

Drugs mentioned

• Yellow fever vaccine (live attenuated yellow fever vaccine)

Snippet

Sponsor: University of Minnesota | Conditions: Yellow Fever | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-10-07